marketcaparena

BHC

Bausch Health Companies Inc.

Company overview

Market capitalization
$2.16B
Employees
20,300
Latest publication
2026-09-29
About Bausch Health Companies Inc.

Bausch Health Companies Inc. operates as a diversified specialty pharmaceutical and medical device company. It operates through five segments: Salix, International, Solta Medical, Diversified, and Bausch + Lomb. The company develops, manufactures, and markets products primarily in the therapeutic areas of gastroenterology, hepatology, neurology and dermatology, generic and branded generic pharmaceuticals, dentistry products, over-the-counter products, aesthetic medical devices, and eye health. The company sells its products in the United States, China, Canada, Poland, Mexico, France, South Korea, Russia, Japan, Germany, the United Kingdom, Spain, Italy, and internationally. The company was formerly known as Valeant Pharmaceuticals International, Inc. and changed its name to Bausch Health Companies Inc. in July 2018. Bausch Health Companies Inc. is headquartered in Laval, Canada.

Company website

Financial statements

Income Quarterly

Exact reported values; units shown beside each amount. Missing values are —.
MetricQ1 20262026-03-31 · USDQ2 20232023-06-30 · USDQ3 20222022-09-30 · USDQ4 20202020-12-31 · USDQ3 20202020-09-30 · USDQ1 20202020-03-31 · USDQ3 20192019-09-30 · USDQ2 20192019-06-30 · USD
Total Revenue2,489,038,232USD2,167,000,000USD2,046,000,000USD2,213,000,000USD2,138,000,000USD2,012,000,000USD2,209,000,000USD2,152,000,000USD
Cost Of Revenue965,439,156USD649,000,000USD584,000,000USD645,000,000USD590,000,000USD519,000,000USD584,000,000USD594,000,000USD
Gross Profit1,523,599,076USD1,518,000,000USD1,462,000,000USD1,568,000,000USD1,548,000,000USD1,493,000,000USD1,625,000,000USD1,558,000,000USD
Research Development160,742,167USD156,000,000USD133,000,000USD132,000,000USD115,000,000USD123,000,000USD124,000,000USD124,000,000USD
Selling General Administrative861,000,000USD711,000,000USD661,000,000USD168,000,000USD572,000,000USD633,000,000USD648,000,000USD651,000,000USD
Unclassified Operating Expenses-11,926,339USD239,000,000USD424,000,000USD822,000,000USD401,000,000USD489,000,000USD524,000,000USD526,000,000USD
Total Operating Expenses1,009,815,828USD1,106,000,000USD1,218,000,000USD1,573,000,000USD1,088,000,000USD1,245,000,000USD1,296,000,000USD1,301,000,000USD
Operating Income513,783,248USD412,000,000USD244,000,000USD-5,000,000USD460,000,000USD248,000,000USD329,000,000USD257,000,000USD
Interest Income10,000,000USD7,000,000USD375,000,000USD381,000,000USD385,000,000USD7,000,000USD2,000,000USD3,000,000USD
Interest Expense396,431,604USD319,000,000USD385,000,000USD379,000,000USD374,000,000USD396,000,000USD406,000,000USD409,000,000USD
Net Interest Income-392,000,000USD-312,000,000USD-382,000,000USD-377,000,000USD-372,000,000USD-389,000,000USD-404,000,000USD-406,000,000USD
Income Before Tax-1,335,244,757USD79,000,000USD439,000,000USD-394,000,000USD75,000,000USD-178,000,000USD-66,000,000USD-179,000,000USD
Income Tax Expense75,933,416USD52,000,000USD36,000,000USD-242,000,000USD5,000,000USD-26,000,000USD-18,000,000USD-9,000,000USD
Tax Provision77,000,000USD52,000,000USD36,000,000USD-242,000,000USD5,000,000USD-26,000,000USD-18,000,000USD-9,000,000USD
Net Income-1,403,288,987USD26,000,000USD399,000,000USD-153,000,000USD71,000,000USD-152,000,000USD-49,000,000USD-171,000,000USD
Net Income From Continuing Ops-1,431,000,000USD27,000,000USD403,000,000USD-152,000,000USD70,000,000USD-152,000,000USD-48,000,000USD-170,000,000USD
Ebit-938,813,153USD381,000,000USD378,000,000USD447,000,000USD482,000,000USD301,000,000USD378,000,000USD296,000,000USD
Ebitda-647,899,414USD696,000,000USD713,000,000USD875,000,000USD918,000,000USD782,000,000USD898,000,000USD827,000,000USD
Depreciation And Amortization290,913,739USD315,000,000USD335,000,000USD428,000,000USD436,000,000USD481,000,000USD520,000,000USD531,000,000USD
Reconciled Depreciation295,000,000USD269,000,000USD335,000,000USD428,000,000USD436,000,000USD481,000,000USD520,000,000USD531,000,000USD
Total Other Income Expense Net-1,849,028,005USD-333,000,000USD195,000,000USD-389,000,000USD-385,000,000USD-426,000,000USD-395,000,000USD-436,000,000USD
Minority Interest8,000,000USD1,000,000USD4,000,000USD1,000,000USD-1,000,000USD71,000,000USD1,000,000USD1,000,000USD
Non Operating Income Net Other—-14,000,000USD580,000,000USD-10,000,000USD-11,000,000USD-30,000,000USD11,000,000USD-27,000,000USD
Net Income Applicable To Common Shares—26,000,000USD399,000,000USD-153,000,000USD71,000,000USD-152,000,000USD-49,000,000USD-171,000,000USD
Selling And Marketing Expenses———451,000,000USD————
SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

Income Yearly

Exact reported values; units shown beside each amount. Missing values are —.
MetricFY 20202020-12-31 · USDFY 20172017-12-31 · USDFY 20142014-12-31 · USDFY 20122012-12-31 · USDFY 20112011-12-31 · USDFY 20102010-12-31 · USDFY 20092009-12-31 · USDFY 20072007-12-31 · USD
Total Revenue8,027,000,000USD8,724,000,000USD8,200,000,000USD3,480,400,000USD2,463,450,000USD1,146,128,000USD820,430,000USD842,818,000USD
Cost Of Revenue2,249,000,000USD2,548,000,000USD2,203,000,000USD890,900,000USD726,832,000USD405,750,000USD325,093,000USD223,680,000USD
Gross Profit5,778,000,000USD6,176,000,000USD5,997,000,000USD2,589,500,000USD1,736,618,000USD740,378,000USD495,337,000USD619,138,000USD
Research Development485,000,000USD369,000,000USD266,000,000USD79,100,000USD174,887,000USD157,556,000USD14,148,000USD118,117,000USD
Selling General Administrative1,916,000,000USD2,120,000,000USD1,591,000,000USD812,862,000USD584,313,000USD367,418,000USD190,388,000USD161,001,000USD
Selling And Marketing Expenses451,000,000USD462,000,000USD435,000,000USD157,600,000USD————
Unclassified Operating Expenses2,250,000,000USD3,123,000,000USD1,704,000,000USD1,458,538,000USD546,828,000USD-180,117,000USD-11,787,000USD151,338,000USD
Total Operating Expenses5,102,000,000USD6,074,000,000USD3,996,000,000USD2,508,100,000USD1,306,028,000USD344,857,000USD192,749,000USD430,456,000USD
Operating Income676,000,000USD102,000,000USD2,001,000,000USD79,685,000USD525,319,434USD-110,085,000USD181,154,000USD188,014,000USD
Interest Income1,551,000,000USD12,000,000USD——————
Interest Expense1,534,000,000USD1,840,000,000USD971,000,000USD481,600,000USD330,442,000USD84,307,000USD25,418,000USD0USD
Net Interest Income-1,521,000,000USD-1,828,000,000USD——————
Income Before Tax-934,000,000USD-1,741,000,000USD1,054,000,000USD-394,228,000USD-18,000,000USD-236,263,000USD174,955,000USD208,739,000USD
Income Tax Expense-375,000,000USD-4,145,000,000USD174,000,000USD-278,203,000USD-177,559,000USD-28,070,000USD-1,500,000USD13,200,000USD
Tax Provision-375,000,000USD-4,145,000,000USD——————
Net Income-559,000,000USD2,404,000,000USD881,000,000USD-116,025,000USD159,559,000USD-208,193,000USD176,455,000USD195,539,000USD
Net Income From Continuing Ops-559,000,000USD2,404,000,000USD912,200,000USD-116,025,000USD159,559,000USD-208,193,000USD——
Ebit1,313,000,000USD555,000,000USD2,298,000,000USD803,100,000USD306,110,594USD-151,956,000USD199,836,000USD188,682,000USD
Ebitda3,138,000,000USD3,413,000,000USD3,912,000,000USD1,789,300,000USD901,348,248USD102,548,000USD349,096,000USD289,450,000USD
Depreciation And Amortization1,825,000,000USD2,858,000,000USD1,614,000,000USD986,200,000USD595,237,654USD254,504,000USD149,260,000USD100,768,000USD
Reconciled Depreciation1,825,000,000USD2,858,000,000USD——————
Total Other Income Expense Net-1,610,000,000USD-1,843,000,000USD-947,000,000USD-473,913,000USD-317,959,000USD-126,178,000USD-6,199,000USD20,725,000USD
Non Operating Income Net Other-76,000,000USD-3,000,000USD23,900,000USD-517,000USD15,082,000USD-41,871,000USD——
Minority Interest1,000,000USD95,000,000USD-1,300,000USD—————
Net Income Applicable To Common Shares-560,000,000USD2,404,000,000USD913,500,000USD-116,025,000USD159,559,000USD-208,193,000USD176,455,000USD195,539,000USD
SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

Balance sheet Quarterly

Exact reported values; units shown beside each amount. Missing values are —.
MetricQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USDQ2 20242024-06-30 · USD
Total Assets24,498,000,000USD26,318,017,834USD26,797,851,964USD27,266,000,000USD26,421,000,000USD26,523,000,000USD26,540,000,000USD26,495,000,000USD
Intangible Assets4,404,000,000USD4,634,550,436USD4,825,291,716USD5,047,000,000USD5,297,000,000USD5,551,000,000USD5,652,000,000USD5,903,000,000USD
Other Current Assets887,000,000USD850,449,489USD893,128,528USD922,000,000USD913,000,000USD858,000,000USD883,000,000USD902,000,000USD
Total Liab25,580,000,000USD25,941,703,918USD26,442,198,993USD27,119,000,000USD26,661,000,000USD26,845,000,000USD26,782,000,000USD26,722,000,000USD
Total Stockholder Equity-2,059,000,000USD-552,991,803USD-564,449,238USD-764,000,000USD-1,183,000,000USD-1,279,000,000USD-1,174,000,000USD-1,175,000,000USD
Other Current Liab3,037,000,000USD3,277,025,433USD3,594,492,668USD3,469,000,000USD3,354,000,000USD3,359,000,000USD3,284,000,000USD3,260,011,440USD
Common Stock10,542,000,000USD10,496,862,457USD10,504,749,978USD10,510,000,000USD10,508,000,000USD10,490,000,000USD10,489,000,000USD10,483,000,000USD
Capital Stock10,542,000,000USD10,516,000,000USD10,515,000,000USD10,510,000,000USD10,508,000,000USD10,490,000,000USD10,489,000,000USD10,483,000,000USD
Retained Earnings-11,090,000,000USD-9,649,407,510USD-9,545,685,786USD-9,734,000,000USD-9,882,000,000USD-9,824,000,000USD-9,917,000,000USD-9,832,000,000USD
Good Will9,807,000,000USD11,250,488,470USD11,275,997,432USD11,298,000,000USD11,153,000,000USD11,087,000,000USD11,171,000,000USD11,127,000,000USD
Cash1,299,000,000USD1,322,588,698USD1,338,693,768USD1,727,000,000USD1,134,000,000USD1,181,000,000USD719,000,000USD595,000,000USD
Cash And Short Term Investments1,299,000,000USD1,322,588,698USD1,338,693,768USD1,727,000,000USD1,134,000,000USD1,181,000,000USD719,000,000USD595,000,000USD
Total Current Assets5,978,000,000USD6,145,795,183USD6,242,908,474USD6,514,000,000USD5,732,000,000USD5,774,000,000USD5,351,000,000USD5,211,000,000USD
Total Current Liabilities4,530,000,000USD4,172,393,027USD4,788,327,783USD4,975,000,000USD4,256,000,000USD6,752,000,000USD4,506,000,000USD4,369,000,000USD
Net Debt19,496,000,000USD19,884,746,767USD19,682,794,490USD20,011,000,000USD20,376,000,000USD20,435,000,000USD20,788,000,000USD21,065,000,000USD
Short Term Debt900,000,000USD296,459,504USD578,435,590USD879,000,000USD282,000,000USD2,674,000,000USD453,000,000USD452,000,000USD
Short Long Term Debt889,000,000USD225,000,000USD579,000,000USD879,000,000USD282,000,000USD2,674,000,000USD453,000,000USD452,000,000USD
Short Long Term Debt Total20,795,000,000USD21,207,335,465USD21,021,488,258USD21,738,000,000USD21,510,000,000USD21,616,000,000USD21,507,000,000USD21,660,000,000USD
Long Term Debt19,875,000,000USD20,592,000,000USD20,463,000,000USD20,859,000,000USD21,228,000,000USD18,942,000,000USD21,054,000,000USD21,208,000,000USD
Net Receivables2,191,000,000USD2,346,721,532USD2,414,643,908USD2,210,000,000USD2,072,000,000USD2,140,000,000USD2,094,000,000USD2,102,000,000USD
Inventory1,601,000,000USD1,626,035,464USD1,596,442,269USD1,655,000,000USD1,613,000,000USD1,595,000,000USD1,655,000,000USD1,612,000,000USD
Accounts Payable593,000,000USD598,908,090USD615,399,523USD627,000,000USD620,000,000USD656,000,000USD667,000,000USD579,000,000USD
Property Plant Equipment Net2,095,000,000USD2,070,225,631USD2,024,025,055USD1,994,000,000USD1,882,000,000USD1,780,000,000USD1,789,000,000USD1,738,000,000USD
Accumulated Other Comprehensive Income-1,806,000,000USD-1,756,797,064USD-1,798,245,360USD-1,790,000,000USD-2,029,000,000USD-2,179,000,000USD-1,947,000,000USD-2,007,000,000USD
Common Stock Shares Outstanding372,800,000shares370,531,987shares375,500,000shares373,100,000shares369,600,000shares372,000,000shares368,400,000shares370,200,000shares
Non Current Assets Total18,520,000,000USD20,172,222,651USD20,554,943,490USD20,752,000,000USD20,689,000,000USD20,749,000,000USD21,189,000,000USD21,284,000,000USD
Non Current Liabilities Total21,050,000,000USD21,769,310,891USD21,653,871,210USD22,144,000,000USD22,405,000,000USD20,093,000,000USD22,276,000,000USD22,353,000,000USD
Non Current Liabilities Other976,000,000USD1,047,000,000USD1,067,000,000USD1,141,000,000USD1,043,000,000USD1,023,000,000USD1,053,000,000USD975,000,000USD
Non Currrent Assets Other369,000,000USD377,312,097USD381,627,626USD388,000,000USD380,000,000USD363,000,000USD389,000,000USD329,000,000USD
Net Working Capital1,448,000,000USD1,977,000,000USD1,456,000,000USD1,539,000,000USD1,476,000,000USD-978,000,000USD845,000,000USD842,000,000USD
Unclassified Non Current Assets1,845,000,000USD-381,353,983USD-383,998,339USD-388,000,000USD-380,000,000USD-363,000,000USD-389,000,000USD2,186,999,999USD
Unclassified Current Liabilities-889,000,000USD-225,000,000USD-578,999,998USD-879,000,000USD-282,000,000USD-2,611,000,000USD-351,000,000USD-452,000,003USD
Unclassified Equity-10,247,000,000USD-10,159,649,686USD-10,240,268,070USD-10,260,000,000USD-10,288,000,000USD-10,256,000,000USD-10,288,000,000USD-10,302,000,000USD
Other Assets—2,221,000,000USD2,432,000,000USD2,413,000,000USD2,357,000,000USD2,331,000,000USD2,577,000,000USD1USD
Cash And Equivalents—1,309,000,000USD1,308,000,000USD1,727,000,000USD1,134,000,000USD1,181,000,000USD719,000,000USD—
Property Plant Equipment Gross—4,498,000,000USD———3,924,000,000USD——
Current Deferred Revenue———————77,988,563USD
SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

Balance sheet Yearly

Exact reported values; units shown beside each amount. Missing values are —.
MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USD
Total Assets26,318,017,834USD26,523,000,000USD27,350,000,000USD25,686,000,000USD29,202,000,000USD31,199,000,000USD33,863,000,000USD27,447,000,000USD
Intangible Assets4,634,550,436USD5,551,000,000USD6,456,000,000USD5,800,000,000USD6,948,000,000USD8,445,000,000USD10,201,000,000USD12,001,000,000USD
Other Current Assets850,449,489USD858,000,000USD1,107,000,000USD803,000,000USD720,000,000USD855,000,000USD780,000,000USD691,000,000USD
Total Liab25,941,703,918USD26,845,000,000USD27,432,000,000USD25,426,000,000USD29,236,000,000USD30,594,000,000USD32,727,000,000USD29,677,000,000USD
Total Stockholder Equity-552,991,803USD-1,279,000,000USD-1,022,000,000USD-692,000,000USD-34,000,000USD605,000,000USD1,063,000,000USD2,733,000,000USD
Other Current Liab3,277,025,433USD3,301,000,000USD3,086,000,000USD2,958,000,000USD4,791,000,000USD4,576,000,000USD4,315,000,000USD3,030,000,000USD
Common Stock10,496,862,457USD10,490,000,000USD10,423,000,000USD10,391,000,000USD10,317,000,000USD10,227,000,000USD10,172,000,000USD10,121,000,000USD
Capital Stock10,516,000,000USD10,490,000,000USD10,423,000,000USD10,391,000,000USD10,317,000,000USD10,227,000,000USD10,172,000,000USD10,121,000,000USD
Retained Earnings-9,649,407,510USD-9,824,000,000USD-9,778,000,000USD-9,186,000,000USD-8,961,000,000USD-8,013,000,000USD-7,452,000,000USD-5,664,000,000USD
Good Will11,250,488,470USD11,087,000,000USD11,183,000,000USD11,547,000,000USD12,457,000,000USD13,044,000,000USD13,126,000,000USD13,142,000,000USD
Other Assets2,006,000,000USD2,120,000,000USD2,223,000,000USD2,271,000,000USD2,345,000,000USD2,801,000,000USD1,830,000,000USD-1,557,000,000USD
Cash1,322,588,698USD1,181,000,000USD947,000,000USD564,000,000USD582,000,000USD605,000,000USD3,243,000,000USD721,000,000USD
Cash And Equivalents1,309,000,000USD1,181,000,000USD947,000,000USD564,000,000USD582,000,000USD605,000,000USD3,243,000,000USD721,000,000USD
Cash And Short Term Investments1,322,588,698USD1,181,000,000USD947,000,000USD564,000,000USD582,000,000USD605,000,000USD3,243,000,000USD721,000,000USD
Total Current Assets6,145,795,183USD5,774,000,000USD5,596,000,000USD4,247,000,000USD5,607,000,000USD5,342,000,000USD6,969,000,000USD723,000,000USD
Total Current Liabilities4,172,393,027USD6,752,000,000USD4,302,000,000USD3,941,000,000USD5,198,000,000USD4,913,000,000USD6,248,000,000USD3,836,000,000USD
Net Debt19,884,746,767USD20,645,009,726USD21,441,000,000USD20,202,000,000USD22,072,000,000USD23,320,000,000USD22,652,000,000USD23,584,000,000USD
Short Term Debt296,459,504USD2,732,000,000USD450,000,000USD432,000,000USD49,932,319USD52,000,000USD1,234,000,000USD228,000,000USD
Short Long Term Debt225,000,000USD2,674,000,000USD450,000,000USD432,000,000USD——1,234,000,000USD228,000,000USD
Short Long Term Debt Total21,207,335,465USD21,826,009,726USD22,388,000,000USD20,766,000,000USD22,703,932,319USD23,977,000,000USD25,895,000,000USD24,305,000,000USD
Long Term Debt20,592,000,000USD18,942,000,000USD21,938,000,000USD20,334,000,000USD22,654,000,000USD23,925,000,000USD24,661,000,000USD24,077,000,000USD
Net Receivables2,346,721,532USD2,140,000,000USD1,998,000,000USD1,790,000,000USD1,775,000,000USD1,577,000,000USD1,839,000,000USD1,865,000,000USD
Inventory1,626,035,464USD1,595,000,000USD1,544,000,000USD1,090,000,000USD993,000,000USD1,094,000,000USD1,107,000,000USD934,000,000USD
Accounts Payable598,908,090USD656,000,000USD719,000,000USD521,000,000USD407,000,000USD337,000,000USD503,000,000USD411,000,000USD
Property Plant Equipment Net2,070,225,631USD1,780,000,000USD1,707,000,000USD1,600,000,000USD1,598,000,000USD1,567,000,000USD1,466,000,000USD1,353,000,000USD
Property Plant Equipment Gross4,498,000,000USD3,924,000,000USD3,790,000,000USD3,520,000,000USD3,418,000,000USD1,567,000,000USD1,466,000,000USD1,353,000,000USD
Accumulated Other Comprehensive Income-1,756,797,064USD-2,179,000,000USD-1,881,000,000USD-2,056,000,000USD-1,924,000,000USD-2,133,000,000USD-2,086,000,000USD-2,137,000,000USD
Common Stock Shares Outstanding375,000,000shares368,000,000shares364,900,000shares362,000,000shares358,900,000shares355,000,000shares352,100,000shares349,871,102shares
Non Current Assets Total20,172,222,651USD20,749,000,000USD21,754,000,000USD21,439,000,000USD23,595,000,000USD25,857,000,000USD26,894,000,000USD28,281,000,000USD
Non Current Liabilities Total21,769,310,891USD20,093,000,000USD23,130,000,000USD21,485,000,000USD24,038,000,000USD25,681,000,000USD26,479,000,000USD25,841,000,000USD
Non Current Liabilities Other1,047,000,000USD1,023,000,000USD1,029,000,000USD949,000,000USD855,000,000USD1,228,000,000USD1,113,000,000USD879,000,000USD
Non Currrent Assets Other377,312,097USD363,000,000USD307,000,000USD326,000,000USD340,000,000USD664,000,000USD411,000,000USD109,000,000USD
Net Working Capital1,977,000,000USD-978,000,000USD1,294,000,000USD306,000,000USD409,000,000USD429,000,000USD721,000,000USD375,000,000USD
Unclassified Current Liabilities-225,000,000USD-2,611,000,000USD-2,495,000,000USD-402,000,000USD—-52,000,000USD-3,432,000,000USD-228,000,000USD
Unclassified Equity-10,159,649,686USD-10,256,000,000USD-10,209,000,000USD-10,232,000,000USD-9,783,000,000USD-9,703,000,000USD-9,743,000,000USD-9,708,000,000USD
Current Deferred Revenue——2,092,000,000USD—-49,932,319USD-52,000,000USD2,394,000,000USD167,000,000USD
Deferred Long Term Liab———202,000,000USD529,000,000USD528,000,000USD705,000,000USD885,000,000USD
Other Liab———967,000,000USD1,170,000,000USD1,529,000,000USD1,578,000,000USD1,764,000,000USD
Net Tangible Assets———-18,039,000,000USD-19,511,000,000USD-20,954,000,000USD-22,264,000,000USD-22,410,000,000USD
Unclassified Non Current Liabilities———-967,000,000USD-1,170,000,000USD-1,529,000,000USD-1,578,000,000USD-1,764,000,000USD
Unclassified Current Assets————1,537,000,000USD1,211,000,000USD—-3,488,000,000USD
Unclassified Non Current Assets—————-664,000,000USD—1,676,000,000USD
SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

Cash flow Quarterly

Exact reported values; units shown beside each amount. Missing values are —.
MetricQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USDQ2 20242024-06-30 · USDQ1 20242024-03-31 · USD
Net Income-113,721,582USD181,000,000USD128,000,000USD-86,000,000USD98,000,000USD-85,683,743USD9,997,937USD-77,000,000USD
Depreciation294,457,668USD306,000,000USD307,000,000USD305,000,000USD307,000,000USD324,590,182USD317,934,417USD320,000,000USD
Stock Based Compensation84,000,000USD43,000,000USD46,000,000USD43,000,000USD43,000,000USD38,000,000USD36,000,000USD33,000,000USD
Other Non Cash Items352,757,808USD-48,000,000USD-241,000,000USD23,000,000USD99,159,000USD41,279,107USD63,395,956USD27,000,000USD
Change To Account Receivables66,280,899USD-218,000,000USD-91,000,000USD110,000,000USD-104,000,000USD23,087,429USD-71,935,623USD-63,000,000USD
Change To Inventory-5,082,496USD16,000,000USD7,000,000USD-30,000,000USD-49,000,000USD-42,182,332USD-32,818,178USD-144,000,000USD
Change In Working Capital-195,341,655USD-53,000,000USD91,000,000USD-65,000,000USD-116,000,000USD126,518,496USD31,511,493USD-35,000,000USD
Total Cash From Operating Activities495,919,506USD405,000,000USD289,000,000USD211,000,000USD601,000,000USD403,686,271USD378,744,097USD211,000,000USD
Capital Expenditures-93,391,278USD-91,000,000USD-99,000,000USD-124,000,000USD-107,000,000USD-71,300,847USD-78,030,635USD-83,000,000USD
Free Cash Flow402,528,228USD314,000,000USD190,000,000USD87,000,000USD494,000,000USD332,385,424USD300,713,461USD128,000,000USD
Investments-3,000,000USD-83,000,000USD-100,000,000USD-130,000,000USD-200,000,000USD-102,000,000USD-79,000,000USD-73,000,000USD
Total Cashflows From Investing Activities-286,711,578USD-83,000,000USD-100,000,000USD-130,000,000USD-200,000,000USD-102,428,024USD-78,957,652USD-73,000,000USD
Net Borrowings-219,000,000USD-705,000,000USD405,000,000USD-118,000,000USD95,000,000USD-164,000,000USD——
Total Cash From Financing Activities-231,654,147USD-719,000,000USD358,000,000USD-146,000,000USD85,000,000USD-186,806,431USD-423,365,399USD-340,000,000USD
Change In Cash-16,105,070USD-403,000,000USD586,000,000USD-44,000,000USD451,000,000USD125,906,065USD-131,313,075USD-207,000,000USD
Begin Period Cash Flow1,338,693,768USD1,743,000,000USD1,157,000,000USD1,201,000,000USD750,000,000USD622,908,633USD754,221,708USD962,000,000USD
End Period Cash Flow1,322,588,698USD1,340,000,000USD1,743,000,000USD1,157,000,000USD1,201,000,000USD748,814,698USD622,908,633USD755,000,000USD
Other Cashflows From Investing Activities-8,627USD13,000,000USD-1,000,000USD-3,000,000USD-5,013,000USD7,029,136USD43,799USD6,000,000USD
Other Cashflows From Financing Activities-9,120,891USD-14,000,000USD-44,000,000USD-28,000,000USD1,583,000USD-22,092,169USD-9,087,764USD-25,000,000USD
Unclassified Operating Cash Flow73,767,267USD-24,000,000USD-42,000,000USD-9,000,000USD169,841,000USD-41,017,771USD-80,095,706USD-57,000,000USD
Unclassified Investing Cash Flow-190,311,673USD78,000,000USD100,000,000USD127,000,000USD112,013,000USD63,843,687USD78,029,184USD77,000,000USD
Unclassified Financing Cash Flow-3,533,256USD———-11,583,000USD-18,714,262USD-410,277,635USD-301,000,000USD
Dividends Paid—0USD0USD0USD—0USD0USD0USD
Sale Purchase Of Stock—3,000,000USD-3,000,000USD—0USD18,000,000USD-4,000,000USD-14,000,000USD
SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

Cash flow Yearly

Exact reported values; units shown beside each amount. Missing values are —.
MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USD
Net Income120,000,000USD-72,000,000USD-611,000,000USD-212,000,000USD-937,000,000USD-559,000,000USD-1,783,000,000USD-4,144,000,000USD
Depreciation1,208,000,000USD1,267,000,000USD1,264,000,000USD1,394,000,000USD1,552,000,000USD1,825,000,000USD2,075,000,000USD2,819,000,000USD
Stock Based Compensation216,000,000USD150,000,000USD132,000,000USD126,000,000USD128,000,000USD105,000,000USD102,000,000USD87,000,000USD
Other Non Cash Items-1,166,289USD179,000,000USD778,000,000USD-1,464,000,000USD1,036,000,000USD581,000,000USD1,655,000,000USD2,865,000,000USD
Change To Account Receivables-136,345,741USD-216,000,000USD-195,000,000USD-57,000,000USD-229,000,000USD170,000,000USD39,000,000USD216,000,000USD
Change To Inventory-12,210,066USD-267,000,000USD-322,000,000USD-198,000,000USD-16,000,000USD-77,000,000USD-209,000,000USD-5,000,000USD
Change In Working Capital-222,833,711USD7,000,000USD-582,000,000USD-396,000,000USD-128,000,000USD-366,000,000USD-318,000,000USD18,000,000USD
Total Cash From Operating Activities1,400,000,000USD1,597,000,000USD1,032,000,000USD-728,000,000USD1,426,000,000USD1,111,000,000USD1,501,000,000USD1,501,000,000USD
Capital Expenditures-397,000,000USD-337,000,000USD-272,000,000USD-268,000,000USD-283,000,000USD-309,000,000USD-278,000,000USD-235,000,000USD
Free Cash Flow1,003,000,000USD1,260,000,000USD760,000,000USD-996,000,000USD1,143,000,000USD802,000,000USD1,223,000,000USD1,266,000,000USD
Investments-3,000,000USD-454,000,000USD-2,133,000,000USD5,000,000USD-4,000,000USD4,000,000USD-6,000,000USD-196,000,000USD
Total Cashflows From Investing Activities-595,000,000USD-454,000,000USD-2,145,000,000USD-303,000,000USD409,000,000USD-261,000,000USD-419,000,000USD-196,000,000USD
Net Borrowings-637,000,000USD-799,000,000USD1,581,000,000USD-1,081,000,000USD-1,388,000,000USD-2,226,000,000USD1,526,000,000USD-1,262,000,000USD
Total Cash From Financing Activities-742,000,000USD-868,000,000USD1,475,000,000USD-474,000,000USD-1,513,000,000USD-2,294,000,000USD1,443,000,000USD-1,353,000,000USD
Change In Cash124,000,000USD239,000,000USD371,000,000USD-1,528,000,000USD303,000,000USD-1,428,000,000USD2,521,000,000USD-74,000,000USD
Begin Period Cash Flow1,201,000,000USD962,000,000USD591,000,000USD2,119,000,000USD1,816,000,000USD3,244,000,000USD723,000,000USD797,000,000USD
End Period Cash Flow1,325,000,000USD1,201,000,000USD962,000,000USD591,000,000USD2,119,000,000USD1,816,000,000USD3,244,000,000USD723,000,000USD
Other Cashflows From Investing Activities-195,000,000USD-119,000,000USD-39,000,000USD-45,000,000USD682,000,000USD37,000,000USD45,000,000USD34,000,000USD
Other Cashflows From Financing Activities-93,848,976USD-43,000,000USD-106,000,000USD-139,000,000USD-173,000,000USD-107,000,000USD-71,000,000USD-186,000,000USD
Unclassified Operating Cash Flow80,000,000USD66,000,000USD51,000,000USD-176,000,000USD-225,000,000USD-475,000,000USD-230,000,000USD-144,000,000USD
Unclassified Financing Cash Flow-11,151,024USD—24,000,000USD808,000,000USD100,000,000USD69,000,000USD28,000,000USD105,000,000USD
Sale Purchase Of Stock—-26,000,000USD-24,000,000USD-31,000,000USD-52,000,000USD-30,000,000USD-40,000,000USD-10,000,000USD
Issuance Of Capital Stock—0USD0USD675,000,000USD0USD0USD——
Unclassified Investing Cash Flow—456,000,000USD299,000,000USD5,000,000USD14,000,000USD7,000,000USD-180,000,000USD201,000,000USD
Change To Liabilities———-75,000,000USD121,000,000USD-471,000,000USD-149,000,000USD-121,000,000USD
Dividends Paid———-31,000,000USD————
Cash And Cash Equivalents Changes———-1,505,000,000USD322,000,000USD-1,444,000,000USD2,525,000,000USD-74,000,000USD
Exchange Rate Changes———————-26,000,000USD
SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

Operating metrics

No operating metrics are currently published for this company.

Revenue breakdown

PeriodDimensionBusiness / regionRevenueCurrencySource
Q1 2026Quarterly · 2026-03-31ProductPrice Appreciation Credit2,000,000USD0000885590-26-000053
Q1 2026Quarterly · 2026-03-31ProductProduct2,500,000,000USD0000885590-26-000053
Q1 2026Quarterly · 2026-03-31ProductProduct And Service Other24,000,000USD0000885590-26-000053
Q1 2026Quarterly · 2026-03-31SegmentBausch Lomb1,244,000,000USD0000885590-26-000053
Q1 2026Quarterly · 2026-03-31SegmentDiversified185,000,000USD0000885590-26-000053
Q1 2026Quarterly · 2026-03-31SegmentInternational Rx285,000,000USD0000885590-26-000053
Q1 2026Quarterly · 2026-03-31SegmentSalix639,000,000USD0000885590-26-000053
Q1 2026Quarterly · 2026-03-31SegmentSolta Medical171,000,000USD0000885590-26-000053
Q4 2025Quarterly · 2025-12-31SegmentBausch Lomb1,405,000,000USDLegacy provider
Q4 2025Quarterly · 2025-12-31SegmentDiversified255,000,000USDLegacy provider
Q4 2025Quarterly · 2025-12-31SegmentInternational Rx306,000,000USDLegacy provider
Q4 2025Quarterly · 2025-12-31SegmentSalix693,000,000USDLegacy provider
Q4 2025Quarterly · 2025-12-31SegmentSolta Medical137,000,000USDLegacy provider
FY 2025Yearly · 2025-12-31GeographyCanada417,000,000USD0000885590-26-000023
FY 2025Yearly · 2025-12-31GeographyChina493,000,000USD0000885590-26-000023
FY 2025Yearly · 2025-12-31GeographyES109,000,000USD0000885590-26-000023
FY 2025Yearly · 2025-12-31GeographyFrance249,000,000USD0000885590-26-000023
FY 2025Yearly · 2025-12-31GeographyGermany176,000,000USD0000885590-26-000023
FY 2025Yearly · 2025-12-31GeographyItaly106,000,000USD0000885590-26-000023
FY 2025Yearly · 2025-12-31GeographyJapan192,000,000USD0000885590-26-000023
FY 2025Yearly · 2025-12-31GeographyMX278,000,000USD0000885590-26-000023
FY 2025Yearly · 2025-12-31GeographyOther Countries1,153,000,000USD0000885590-26-000023
FY 2025Yearly · 2025-12-31GeographyPL382,000,000USD0000885590-26-000023
FY 2025Yearly · 2025-12-31GeographyRU198,000,000USD0000885590-26-000023
FY 2025Yearly · 2025-12-31GeographySouth Korea234,000,000USD0000885590-26-000023
FY 2025Yearly · 2025-12-31GeographyUnited Kingdom141,000,000USD0000885590-26-000023
FY 2025Yearly · 2025-12-31GeographyUnited Statesand Puerto Rico6,138,000,000USD0000885590-26-000023
FY 2025Yearly · 2025-12-31ProductBrandedand Other Generic Products962,000,000USD0000885590-26-000023
FY 2025Yearly · 2025-12-31ProductDevice Products2,439,000,000USD0000885590-26-000023
FY 2025Yearly · 2025-12-31ProductOther Revenues110,000,000USD0000885590-26-000023
FY 2025Yearly · 2025-12-31ProductOverthe Counter Products2,008,000,000USD0000885590-26-000023
FY 2025Yearly · 2025-12-31ProductPharmaceutical Products4,747,000,000USD0000885590-26-000023
FY 2025Yearly · 2025-12-31ProductPrice Appreciation Credit18,000,000USD0000885590-26-000023
FY 2025Yearly · 2025-12-31SegmentBausch Lomb5,101,000,000USD0000885590-26-000023
FY 2025Yearly · 2025-12-31SegmentDiversified937,000,000USD0000885590-26-000023
FY 2025Yearly · 2025-12-31SegmentInternational Rx1,132,000,000USD0000885590-26-000023
FY 2025Yearly · 2025-12-31SegmentSalix2,578,000,000USD0000885590-26-000023
FY 2025Yearly · 2025-12-31SegmentSolta Medical518,000,000USD0000885590-26-000023
Q3 2025Quarterly · 2025-09-30ProductProduct2,657,000,000USD0000885590-25-000051
Q3 2025Quarterly · 2025-09-30ProductProduct And Service Other24,000,000USD0000885590-25-000051
Q3 2025Quarterly · 2025-09-30SegmentBausch Lomb1,281,000,000USD0000885590-25-000051
Q3 2025Quarterly · 2025-09-30SegmentDiversified258,000,000USD0000885590-25-000051
Q3 2025Quarterly · 2025-09-30SegmentInternational Rx286,000,000USD0000885590-25-000051
Q3 2025Quarterly · 2025-09-30SegmentSalix716,000,000USD0000885590-25-000051
Q3 2025Quarterly · 2025-09-30SegmentSolta Medical140,000,000USD0000885590-25-000051
Q2 2025Quarterly · 2025-06-30ProductProduct2,504,000,000USD0000885590-25-000032
Q2 2025Quarterly · 2025-06-30ProductProduct And Service Other26,000,000USD0000885590-25-000032
Q2 2025Quarterly · 2025-06-30SegmentBausch Lomb1,278,000,000USD0000885590-25-000032
Q2 2025Quarterly · 2025-06-30SegmentDiversified219,000,000USD0000885590-25-000032
Q2 2025Quarterly · 2025-06-30SegmentInternational Rx278,000,000USD0000885590-25-000032
Q2 2025Quarterly · 2025-06-30SegmentSalix627,000,000USD0000885590-25-000032
Q2 2025Quarterly · 2025-06-30SegmentSolta Medical128,000,000USD0000885590-25-000032
Q1 2025Quarterly · 2025-03-31ProductPrice Appreciation Credit2,000,000USD0000885590-26-000053
Q1 2025Quarterly · 2025-03-31ProductProduct2,227,000,000USD0000885590-26-000053
Q1 2025Quarterly · 2025-03-31ProductProduct And Service Other32,000,000USD0000885590-26-000053
Q1 2025Quarterly · 2025-03-31SegmentBausch Lomb1,137,000,000USD0000885590-26-000053
Q1 2025Quarterly · 2025-03-31SegmentDiversified205,000,000USD0000885590-26-000053
Q1 2025Quarterly · 2025-03-31SegmentInternational Rx262,000,000USD0000885590-26-000053
Q1 2025Quarterly · 2025-03-31SegmentSalix542,000,000USD0000885590-26-000053
Q1 2025Quarterly · 2025-03-31SegmentSolta Medical113,000,000USD0000885590-26-000053
Q4 2024Quarterly · 2024-12-31SegmentBausch Lomb1,280,000,000USDLegacy provider
Q4 2024Quarterly · 2024-12-31SegmentDiversified228,000,000USDLegacy provider
Q4 2024Quarterly · 2024-12-31SegmentInternational Rx279,000,000USDLegacy provider
Q4 2024Quarterly · 2024-12-31SegmentSalix634,000,000USDLegacy provider
Q4 2024Quarterly · 2024-12-31SegmentSolta Medical138,000,000USDLegacy provider
FY 2024Yearly · 2024-12-31GeographyCanada402,000,000USD0000885590-26-000023
FY 2024Yearly · 2024-12-31GeographyChina496,000,000USD0000885590-26-000023
FY 2024Yearly · 2024-12-31GeographyES99,000,000USD0000885590-26-000023
FY 2024Yearly · 2024-12-31GeographyFrance230,000,000USD0000885590-26-000023
FY 2024Yearly · 2024-12-31GeographyGermany159,000,000USD0000885590-26-000023
FY 2024Yearly · 2024-12-31GeographyItaly94,000,000USD0000885590-26-000023
FY 2024Yearly · 2024-12-31GeographyJapan188,000,000USD0000885590-26-000023
FY 2024Yearly · 2024-12-31GeographyMX315,000,000USD0000885590-26-000023
FY 2024Yearly · 2024-12-31GeographyOther Countries1,083,000,000USD0000885590-26-000023
FY 2024Yearly · 2024-12-31GeographyPL350,000,000USD0000885590-26-000023
FY 2024Yearly · 2024-12-31GeographyRU161,000,000USD0000885590-26-000023
FY 2024Yearly · 2024-12-31GeographySouth Korea146,000,000USD0000885590-26-000023
FY 2024Yearly · 2024-12-31GeographyUnited Kingdom135,000,000USD0000885590-26-000023
FY 2024Yearly · 2024-12-31GeographyUnited Statesand Puerto Rico5,767,000,000USD0000885590-26-000023
FY 2024Yearly · 2024-12-31ProductBrandedand Other Generic Products979,000,000USD0000885590-26-000023
FY 2024Yearly · 2024-12-31ProductDevice Products2,240,000,000USD0000885590-26-000023
FY 2024Yearly · 2024-12-31ProductOther Revenues107,000,000USD0000885590-26-000023
FY 2024Yearly · 2024-12-31ProductOverthe Counter Products1,903,000,000USD0000885590-26-000023
FY 2024Yearly · 2024-12-31ProductPharmaceutical Products4,396,000,000USD0000885590-26-000023
FY 2024Yearly · 2024-12-31ProductPrice Appreciation Credit18,000,000USD0000885590-26-000023
FY 2024Yearly · 2024-12-31SegmentBausch Lomb4,791,000,000USD0000885590-26-000023
FY 2024Yearly · 2024-12-31SegmentDiversified950,000,000USD0000885590-26-000023
FY 2024Yearly · 2024-12-31SegmentInternational Rx1,111,000,000USD0000885590-26-000023
FY 2024Yearly · 2024-12-31SegmentSalix2,333,000,000USD0000885590-26-000023
FY 2024Yearly · 2024-12-31SegmentSolta Medical440,000,000USD0000885590-26-000023
Q4 2024Quarterly · 2024-12-31GeographyCanada109,000,000USDLegacy provider
Q4 2024Quarterly · 2024-12-31GeographyChina145,000,000USDLegacy provider
Q4 2024Quarterly · 2024-12-31GeographyES28,000,000USDLegacy provider
Q4 2024Quarterly · 2024-12-31GeographyFrance52,000,000USDLegacy provider
Q4 2024Quarterly · 2024-12-31GeographyGermany34,000,000USDLegacy provider
Q4 2024Quarterly · 2024-12-31GeographyItaly23,000,000USDLegacy provider
Q4 2024Quarterly · 2024-12-31GeographyJapan52,000,000USDLegacy provider
Q4 2024Quarterly · 2024-12-31GeographyMX67,000,000USDLegacy provider
Q4 2024Quarterly · 2024-12-31GeographyOther Countries292,000,000USDLegacy provider
Q4 2024Quarterly · 2024-12-31GeographyPL94,000,000USDLegacy provider

Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.